PMDA drug package insert
テクネMDPキット
PMDA Prescription drug · PDRファーマ株式会社 · package insert Mar 28, 2022
Key facts
| Brand names | テクネMDPキット |
|---|---|
| Nonproprietary names | メチレンジホスホン酸 |
| Companies | 製造販売元／PDRファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 放射性医薬品／骨疾患診断薬・脳腫瘍及び脳血管障害診断薬 |
| Therapeutic category codes | 874300 |
| YJ codes | 4300410D1026 |
| Approval numbers | 15300AMZ00855000 |
| Package insert edition | 第2版 |
| Package insert date | Mar 28, 2022 |
| PMDA document key | 651410_4300410D1026_2 |
| PMDA company code | 651410 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: